The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics-Reference-Cited by-同舟云学术

The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics

Published:2004-04 Issue:2 Volume:10 Page:101-112
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Massie Barry M.,Krol William F.,Ammon Susan E.,Armstrong Paul W.,Cleland John G.,Collins Joseph F.,Ezekowitz Michael,Jafri Syed M.,O'Connor Christopher M.,Packer Milton,Schulman Kevin A.,Teo Koon,Warren Stuart

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference51 articles.

1. The use of dicumarol as an adjunct to the treatment of congestive heart failure;Anderson;South Med J,1948

2. Dicumarol therapy in congestive heart failure;Wishart;N Engl J Med,1948

3. Dicumarol prophylaxis of thromboembolic disease in congestive heart failure;Harvey;N Engl J Med,1950

4. A study of the beneficial effects of anticoagulant therapy in congestive heart failure;Griffith;Ann Intern Med,1952

5. Idiopathic cardiomyopathy: clinical features, prognosis, and therapy;Segal;Curr Probl Cardiol,1978

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Prevention After Cardioembolic Stroke;Ischemic Stroke Therapeutics;2024

2. The Dilemma of Use of Anticoagulation in Patients With Heart Failure With Reduced Ejection Fraction and Sinus Rhythm: A Case Report and Literature Review;Cureus;2023-02-20

3. Left Atrial Dilatation and Reduced Left Ventricular Ejection Fraction Are Associated With Cardioembolic Stroke;Frontiers in Neurology;2021-09-13

4. Non-vitamin K antagonist oral anticoagulants for heart diseases;Terapevticheskii arkhiv;2017-09-15

5. Dilated Cardiomyopathy and Cardioskeletal Involvement;Cardioskeletal Myopathies in Children and Young Adults;2017